Skip to content
Dose Brief
Menu
Head-to-head · Brief Score

Amazon One Medical vs AskRx

Two GLP-1 desks, one scoreboard. We put Amazon One Medical and AskRx head-to-head on the published Brief Score — the same six factors, scored the same way.

Higher Brief ScoreNo. 22 · Grade B

Amazon One Medical

Visit Amazon One Medical Full brief →
vs
No. 63 · Grade C

AskRx

Visit AskRx Full brief →

The verdict

Amazon One Medical takes this head-to-head.

Amazon One Medical scores 86 to 77 on our six-factor Brief Score — The most recognizable name in the ranking — Amazon's One Medical routes brand-name GLP-1 care through real primary-care clinicians, but keeps pricing off the record.

That doesn't make AskRx a bad call — it's best for people who want a brand-name-only glp-1 prescriber routing to novocare or lillydirect. Weigh the six factors below against your own priorities before you decide.

Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Brief Score.

Factor by factor

Both desks scored on the six published Brief Score factors. The higher score in each row is marked. See the methodology.

Price Stability
80
46
Supply Reliability
90
81
Transparency
78
88
Access Breadth
88
96
Clinical Oversight
91
82
Track Record
90
80
Amazon One MedicalBrief Score 86 · 77AskRx

Price, coverage & the tracker

Amazon One MedicalAskRx
Brief Score86/100 (B)77/100 (C)
SemaglutideNot disclosedFrom $349/mo (all doses, brand-name)
TirzepatideNot disclosedFrom $299/mo (2.5 mg dose, brand-name)
CoverageAll 50 statesAll 50 states
Brand-name accessYesYes
Oral / sublingualInjection onlyInjection only
On the trackerStableprice stableNewnew to the tracker, no prior reading

Amazon One Medical: Brand-access model through One Medical clinicians; compounded pricing isn't published, so there's no sticker to track.

AskRx: New to the tracker on 1 August 2026. The published line reads From $299/mo (2.5 mg dose, brand-name) at our first reading; there is no earlier reading of ours to compare it against yet.

Not sold on either?

CoreAge Rx tops the whole ranking at 94/100.

The steadiest desk in the ranking: one flat, no-step-up price on both molecules, nationwide, and it hasn't moved.

Keep comparing

Pricing, states and access reflect each provider's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.